A brief primer on the muscle preservation and anti-inflammatory treatment approach to Duchenne, and updates from relevant companies in the space. These presentations will be followed by a moderated Q&A opportunity.
Vice President, Patient Advocacy & External Innovation
Robert Halter, PharmD
Field Medical Director, South/Southwest Santhera Pharmaceuticals
Karyn Koladicz, MD
Executive Medical Director for Medical Affairs, Neurology PTC Therapeutics
Linda Marbán , PhD
President, CEO and Director Capricor Therapeutics